Navigation Links
PTC Therapeutics Reports Third Quarter 2013 Financial and Corporate Results
Date:11/14/2013

clinical trial evaluating our investigational new drug ataluren as a potential treatment for patients with nonsense mutation Duchenne muscular dystrophy (nmDMD). The study is on-track to complete enrollment by mid-2014. The Phase 3 study is expected to be conducted at 53 clinical sites across 18 countries.
  • EMA regulatory process progressing: Following the October 2012 submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for conditional approval of ataluren in nmDMD, the regulatory process continues to progress.  The Committee for Medicinal Products for Human Use (CHMP) has recently notified us that it intends to convene a Scientific Advisory Group (SAG) meeting as part of the regulatory review process.  The SAG meeting may shift the timing of a final opinion from the CHMP on the conditional approval of ataluren in nmDMD from the last quarter of 2013 to the first quarter of 2014.  To manage our regulatory priorities, PTC also plans to delay the filing of an MAA for conditional approval of ataluren in nonsense mutation cystic fibrosis (nmCF) until the first quarter of 2014.
  • Third Quarter 2013 Financial Highlights:

  • Cash, cash equivalents, and marketable securities totaled $157.2 million at September 30, 2013 compared to $2.7 million at December 31, 2012.  The increase was primarily a result of receiving net proceeds of $60.8 million from PTC's equity private placement and $131.6 million from PTC's initial public offering in the first half of 2013 combined with a $10 million milestone achieved in the third quarter of 2013 from Roche for the selection of a development candidate in our SMA collaboration.
  • Revenue from grants and collaborations was $16.3 million for the third quarter of 2013, compared to $7.2 million for the same period in 2012.  The increase was primarily the result of the achievement of a $10 million milestone in our Roche collaboration. Collaborati
    '/>"/>

  • SOURCE PTC Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Aratana Therapeutics Reports Third Quarter 2013 Financial Results
    2. Levi & Korsinsky, LLP Launches Investigation of SAREPTA THERAPEUTICS, INC. for Possible Violations of Federal Securities Laws
    3. Argos Therapeutics to Present at the Elsevier Therapeutic Area Partnerships Meeting
    4. Mirati Therapeutics Reports Third Quarter 2013 Financial Results
    5. Sorrento Therapeutics Adopts Stockholder Rights Plan
    6. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
    7. Shield Therapeutics Files Investigational New Drug Application for ST10 for the Treatment of Iron Deficiency in Chronic Kidney Disease
    8. Cara Therapeutics Files Registration Statement for Proposed Initial Public Offering
    9. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    10. Echo Therapeutics Announces Third Quarter 2013 Financial Results
    11. Halozyme Therapeutics To Present At The Credit Suisse Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... Massachusetts and LONDON , August ... approach seamlessly connects ... continuum improving outcomes and the ...  (NYSE: PHG AEX: PHIA) today announced its presence at  ... latest cardiology solutions, including Heart Model A.I. , EchoNavigator and ...
    (Date:8/27/2015)...  A recent study by Feucht et al, ... Arthrosurface HemiCAP® Wave implant, which is based on ... implant for isolated patellofemoral disease. While both implant ... scores, none of the patients in the "inlay" ... of the patients in the "onlay" group, showed ...
    (Date:8/27/2015)... 27, 2015 ieCrowd™ today announced the ... development of the company,s supplemental oxygen delivery device, ... being developed by ieCrowd,s subsidiary Smart Oxygen Solutions ... demand for oxygen based on level of activity.  ... for the Smart Oxygen device would require a ...
    Breaking Medicine Technology:Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
    ... 2011 Prescription monitoring laboratory and clinical partner ... its Safe Use Treatment Monitoring Solution™. Consistent with ... compliant with the FDA,s Opioid Risk and Evaluation ... for controlled substances.  The program aims to support ...
    ... As NFL coaches and players face a dramatically shortened ... preparation will be gaining a competitive edge as it defends ... Polar USA and the Atlanta Falcons announced that the Polar ... Rate Training System" of the Atlanta Falcons. In ...
    Cached Medicine Technology:Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution 2Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 2Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 3
    (Date:8/28/2015)... ... 28, 2015 , ... CARF International announced that West Ridge ... treatment and intensive family based services. , By pursuing and achieving accreditation, West ... of excellence. As a nonprofit charity for more than 50 years, West Ridge ...
    (Date:8/28/2015)... ... , ... Northridge dentists Dr. Elyson and Dr. Assili are now ... currently receive a one hour treatment of this teeth whitening option. Zoom whitening ... of unique features that can turn teeth up to nine shades whiter. Effective on ...
    (Date:8/28/2015)... Va. (PRWEB) , ... August 28, 2015 , ... ... , which is dedicated to distributing health information technology innovation to transform quality ... survey. Results of the survey will be de-identified and aggregated before being publicly ...
    (Date:8/28/2015)... , ... August 28, 2015 , ... ... of the top 5 millionaire dating sites . According to the listings, ... the second best in this category. , A spokesperson of Top5MillionaireDatingSites.com ...
    (Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered by healthcare consulting ... Services’ (CMS) proposal to mandate bundled payments through the Comprehensive Care for ... Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 noon EDT on ...
    Breaking Medicine News(10 mins):Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:Top5MillionaireDatingSites.com Publishes Its First List of Reviews of the Best Millionaire Dating Sites 2Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3
    ... scientists suggests a safer way to treat medulloblastoma, a ... found that one of the brains signaling pathways inhibits ... , The researchers discovered that three proteins, designated BMP2, ... and induced the malignant cells to develop into normal ...
    ... Orlando, Fla., is,known for theme parks and sun, but ... Turkey, and Italy will come to,Orlando for a different ... to learn the latest about robotic surgery., This ... at Florida Hospital, and led by the world,s leaders ...
    ... testing of all imported heparin , , FRIDAY, March 14 ... which has been linked to hundreds of allergic reactions and ... to a Chinese plant that processed raw ingredients for the ... the U.S. Food and Drug Administration said it will start ...
    ... Bedford, Mass. has developed a way of examining brain ... disease. , In the March 15 issue of ... of America, the team describes how they used optical ... and correctly identified which samples came from people who ...
    ... 14 MedQuist Inc.,(Pink Sheets: MEDQ.PK). On March ... with the individual named plaintiffs and certain,other putative ... Broward customer class action. As previously announced, on ... against the company and certain,present and former officers ...
    ... used insulin fared worse than white counterparts , , FRIDAY, ... with insulin-treated diabetes are less likely to monitor their ... , The researchers examined data on 16,630 Hispanic, black ... diabetes to come to this conclusion. , At every ...
    Cached Medicine News:Health News:St. Jude finds signaling system that halts the growth of a childhood brain cancer 2Health News:St. Jude finds signaling system that halts the growth of a childhood brain cancer 3Health News:Robotic Surgeons From Around the World Attend One-of-a-Kind Conference by Global Robotics Institute at Florida Hospital 2Health News:Blood-Thinner Contaminant Traced to Chinese Plant 2Health News:Blood-Thinner Contaminant Traced to Chinese Plant 3Health News:Researchers use light to detect Alzheimer's 2Health News:Researchers use light to detect Alzheimer's 3Health News:MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation 2Health News:MedQuist Announces Entry Into Settlement Term Sheet Resolving South Broward Litigation 3Health News:Minorities, Poor Have Tougher Time Monitoring Diabetes 2
    ... System is the newest real-time PCR instrument ... instrument offers six detection channels that provide ... 670, and 710nm. Perform rapid PCR due ... working with glass capillaries. Virtually any published ...
    ... detection of SYBR Green I or FAM ... of fluorophores in the second channel ... for a multitude of applications such as ... cycler offers precision thermal control and a ...
    Mx3000P instrument, notebook computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, H...
    Mx3000P instrument, notebook computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, H...
    Medicine Products: